Pacific Biosciences of California Inc (PACB)
1.675
-0.19
(-9.95%)
USD |
NASDAQ |
May 08, 15:11
Pacific Biosciences of California Cash from Operations (Quarterly): -57.56M for Dec. 31, 2023
Cash from Operations (Quarterly) Chart
Historical Cash from Operations (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -57.56M |
| September 30, 2023 | -65.18M |
| June 30, 2023 | -41.74M |
| March 31, 2023 | -94.69M |
| December 31, 2022 | -60.57M |
| September 30, 2022 | -63.05M |
| June 30, 2022 | -60.56M |
| March 31, 2022 | -79.03M |
| December 31, 2021 | -31.71M |
| September 30, 2021 | -40.66M |
| June 30, 2021 | -15.71M |
| March 31, 2021 | -23.10M |
| December 31, 2020 | -14.26M |
| September 30, 2020 | -17.81M |
| June 30, 2020 | -23.79M |
| March 31, 2020 | 75.36M |
| December 31, 2019 | -18.18M |
| September 30, 2019 | -17.26M |
| June 30, 2019 | -17.56M |
| March 31, 2019 | -25.31M |
| December 31, 2018 | -18.98M |
| September 30, 2018 | -14.18M |
| June 30, 2018 | -14.50M |
| March 31, 2018 | -18.77M |
| December 31, 2017 | -20.20M |
| Date | Value |
|---|---|
| September 30, 2017 | -17.84M |
| June 30, 2017 | -12.81M |
| March 31, 2017 | -16.67M |
| December 31, 2016 | -12.90M |
| September 30, 2016 | -15.88M |
| June 30, 2016 | -18.88M |
| March 31, 2016 | -20.27M |
| December 31, 2015 | -0.714M |
| September 30, 2015 | -15.77M |
| June 30, 2015 | -7.494M |
| March 31, 2015 | -23.91M |
| December 31, 2014 | -15.36M |
| September 30, 2014 | -6.235M |
| June 30, 2014 | -13.62M |
| March 31, 2014 | -16.26M |
| December 31, 2013 | -14.57M |
| September 30, 2013 | 18.72M |
| June 30, 2013 | -16.41M |
| March 31, 2013 | -17.58M |
| December 31, 2012 | -18.22M |
| September 30, 2012 | -17.65M |
| June 30, 2012 | -23.61M |
| March 31, 2012 | -17.34M |
| December 31, 2011 | -14.77M |
| September 30, 2011 | -23.85M |
Cash From Operations Definition
Cash flow from operations is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall operating activities of the company. A few examples of operating activities include change in receivables, change in inventories, and changes in current assets.
Cash from Operations (Quarterly) Range, Past 5 Years
-94.69M
Minimum
Mar 2023
75.36M
Maximum
Mar 2020
-35.11M
Average
-31.71M
Median
Dec 2021
Cash from Operations (Quarterly) Benchmarks
| AtriCure Inc | -21.02M |
| BioSig Technologies Inc | -2.942M |
| Intellia Therapeutics Inc | -93.05M |
| Shockwave Medical Inc | 35.84M |
| Outset Medical Inc | -24.44M |
Cash from Operations (Quarterly) Related Metrics
| Cash from Investing (Quarterly) | -66.58M |
| Cash from Financing (Quarterly) | -81.60M |
| Free Cash Flow | -268.02M |
| Free Cash Flow Per Share (Quarterly) | -0.2229 |
| Free Cash Flow to Equity (Quarterly) | -60.32M |
| Free Cash Flow to Firm (Quarterly) | -56.04M |
| Free Cash Flow Yield | -63.10% |